Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 433 | 58 | 109 | 66 | 66 |
| Cost of Goods | 325 | 62 | 264 | 43 | 31 |
| Gross Profit | 108 | -4 | -155 | 23 | 35 |
| Operating Expenses | 3,952 | 4,734 | 4,577 | 4,251 | 3,834 |
| Operating Income | -3,519 | -4,676 | -4,468 | -4,185 | -3,768 |
| Interest Expense | 0 | 0 | 0 | 0 | 92 |
| Other Income | -196 | 275 | 89 | -100 | 0 |
| Pre-tax Income | -3,715 | -4,401 | -4,379 | -4,285 | -3,860 |
| Net Income Continuous | -3,715 | -4,401 | -4,379 | -4,285 | -3,860 |
| Net Income | $-3,715 | $-4,401 | $-4,379 | $-4,285 | $-3,860 |
| EPS Basic Total Ops | -0.33 | -0.38 | -0.40 | -0.39 | -0.36 |
| EPS Basic Continuous Ops | -0.33 | -0.39 | -0.40 | -0.39 | -0.36 |
| EPS Diluted Total Ops | -0.33 | -0.38 | -0.40 | -0.39 | -0.36 |
| EPS Diluted Continuous Ops | -0.33 | -0.39 | -0.40 | -0.39 | -0.36 |
| EBITDA(a) | $-3,239 | $-4,382 | $-4,187 | $-3,924 | $-3,528 |